City of Hope to present breakthroughs in blood cancer, microbiome research and cellular therapies at ASH 2025

With 105 sessions covering topics that include CAR T cell therapy, transplant innovations and precision medicine, City of Hope is shaping the future of hematology care for patients.

2025-11-12

(Press-News.org) LOS ANGELES — City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will present leading-edge findings at the 2025 American Society of Hematology (ASH) Annual Meeting and Exposition happening Dec. 6-9 in Orlando and online.

Across 105 sessions, City of Hope experts will highlight advances in blood cancer research, cellular therapies and precision medicine.

The ASH meeting is the world’s largest hematology gathering, attracting more than 30,000 hematology professionals globally.

“ASH is where the future of hematology takes shape,” said Marcel van den Brink, M.D., Ph.D., City of Hope chief physician executive and president of City of Hope National Medical Center. “Our teams are proud to share discoveries that deepen scientific understanding and accelerate progress toward more effective, safer treatments for patients worldwide.”

From innovative immunotherapies to strategies that improve transplant outcomes, City of Hope is leading progress in areas that matter most to patients.

ORAL ABSTRACT SESSIONS

Leukemia

Plenary 6: Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia
Time: Sunday, Dec. 7, 3:45 p.m. EST
Senior Author: Ibrahim Aldoss, M.D., City of Hope associate professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation

443: CD19-CAR T cell therapy as a definitive consolidation in older adults with b-ALL in CR1 is safe and induces durable MRD-remission
Time: Sunday, Dec. 7, 10:30 a.m. EST
Presenter: Ibrahim Aldoss, M.D., City of Hope associate professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation

Lymphoma

151: 3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma
Time: Saturday, Dec. 6, noon EST
Presenter: Alex Herrera, M.D., City of Hope professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation

268: BAFFR-CAR T cells (PMB-CT01) demonstrate durable responses and manageable toxicities in relapsed/refractory B-cell lymphomas with prior CD19-directed therapy failure or CD19-negative disease
Time: Saturday, Dec. 6, 2:45 p.m. EST
Presenter: Elizabeth Budde, M.D., Ph.D., City of Hope associate professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation

883: Interim analysis of the phase II study of glofitamab, lenalidomide and venetoclax (GLOVe) in untreated patients w/ high-risk mantle cell lymphoma. Response and safety outcomes after the completion of stage 1 of 2 enrollment.
Time: Monday, Dec. 8 at 2:45 p.m. EST
Presenter: Tycel Phillips, M.D., associate professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation

1013: CAR T cell therapy outcomes in adolescent and young adult patients with non-Hodgkin lymphoma
Time: Monday, Dec. 8, 5:30 p.m. EST
Presenter: Lindsey Murphy, M.D., M.S., City of Hope assistant professor, Department of Pediatrics

Myeloma

405: Safety and efficacy of out-of-specification ciltacabtagene autoleucel (cilta-cel) in relapsed/refractory multiple myeloma (RRMM)
Time: Saturday, Dec. 6, 4:30 p.m. EST
Presenter: Azra Borogovac, M.D., M.S., City of Hope assistant professor, Department of Hematology & Hematopoietic Cell Transplantation

Transplantation

376: Total marrow and lymphoid irradiation (TMLI) with fludarabine-melphalan (FM) conditioning for matched donor hematopoietic cell transplant (HCT) in older patients with relapsed/refractory (R/R) disease
Time: Saturday, Dec. 6, 4:45 p.m. EST
Presenter: Monzr M. Al Malki, M.D., City of Hope professor, Department of Hematology & Hematopoietic Cell Transplantation

276: First-in-human trial of allogeneic CD6-CAR tregs in patients with chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation
Time: Saturday, Dec. 6, 3:15 p.m. EST
Presenter: Amandeep Salhotra, M.D., City of Hope associate professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation

160: A TLR4-HSP70 efferocytic program in thymic macrophages sustains thymic homeostasis and T cell output
Time: Saturday, Dec. 6, 12:45 p.m. EST
Presenter: Andri Lemarquis, M.D., Ph.D., City of Hope staff scientist

CITY OF HOPE-LED EDUCATIONAL SESSIONS

14th Annual BMT & Cell Therapy Winter Workshop, co-chaired by Dr. Marcel van den Brink
Time: Friday, Dec. 5, 1:30 – 8 p.m. EST
Register for virtual attendance here.

Satellite Symposia fss25-93: Moving Forward in B-ALL: Insights on Modern and Emerging Standards With Off-the-Shelf Bispecific Antibodies
Time: Friday, Dec. 5, 7 a.m. EST
Presenter: Ibrahim Aldoss, M.D., City of Hope associate professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation

Scientific Workshop on State of the Art (ws25-58): Integrating Functional and Genomic Precision Medicine for Hematologic Malignancies
Time: Friday, Dec. 5, 3 p.m. EST
Chair: Pamela Becker, M.D., Ph.D., professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation

Scientific Workshop: Microbiome and Diet and Cancer Immunotherapy
Time: Friday, Dec. 5, 3:06 p.m. EST
Presenter: Marcel van den Brink, M.D., Ph.D., City of Hope chief physician executive

How I Treat: How I Incorporate Novel Therapies into Hodgkin Lymphoma Treatment: Frontline vs. Relapse
Time: Sunday, Dec. 7 at 8 a.m. EST
Presenter: Alex Herrera, M.D., City of Hope professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation

Educational Spotlight: Measures to Minimize Infection Risk in Immunocompromised Patients after Cellular Therapies — How, for Whom, for How Long?
Time: Monday, Dec. 8, 4:30 p.m. EST
Presenter: Randy Taplitz, M.D., City of Hope professor, Department of Medicine

# # #

About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.  

END

ELSE PRESS RELEASES FROM THIS DATE:

‘Cool’ signs based on a new colorful, flexible electronic display technology

2025-11-12

Electronic signs are all around us, giving directions or advertising the latest gadget. In ACS Energy Letters, researchers report that they’ve developed a dynamic display technology that dissipates heat instead of generating it when the color changes, cooling the surface underneath. They also showed the display could be attached to flexible backings and wrapped over skin. The passive cooling mechanism could usher in the next generation of sustainable, flexible outdoor signs and smart devices. “The technology could be used on building billboards to show ads and also help passively cool a building’s ...

Bees thrive in overlooked pockets of Puget Sound

2025-11-12

PULLMAN, Wash. -- To the casual observer, it’s nothing more than an abandoned golf course. But the land, along with other weedy, minimally maintained “marginal lands” in the Puget Sound area, is home to scores of wild bee species, including many never found before in Snohomish and King counties, according to a seven-year study by Washington State University researchers and others. The survey of bees at three plots of land near airports and beneath power lines adds to the evidence that small corners of largely untended land can sustain bee populations amid the concrete and asphalt landscape of cities ...

PLOS launches two journals to address critical real-world challenges

2025-11-12

SAN FRANCISCO — The Public Library of Science (PLOS) today announced the launch of two journals, PLOS Aging and Health and PLOS Ecosystems. Both journals are grounded in our commitment to rigor and research integrity of the highest standard and our open science principles, which facilitates greater reproducibility, faster scientific progress, and broader access to knowledge. In addition, both journals are underpinned by our Flat Fee model that is designed to shift the cost from researchers to an institutional annual fee, which enables institutions to provide unlimited publishing opportunities ...

Year-round edamame: hydroponic LED plant factories redefine sustainable cultivation

2025-11-12

Artificial light-type plant factories are an emerging agricultural innovation that enable crops to be grown year-round in precisely controlled environments. By adjusting factors such as light, temperature, humidity, carbon dioxide concentration, and nutrient delivery, these facilities can produce stable yields independent of climate conditions. They offer a promising way to reduce pesticide use and minimize the impacts of climate change. However, legumes like edamame have long been considered difficult to cultivate in such settings because of their long growth periods, short storage periods, complex flowering, and pod-setting processes. Against this backdrop, the research ...

Pusan National University researchers explore smart nanomaterials that detect and treat traumatic brain injuries simultaneously

2025-11-12

Traumatic brain injury (TBI) remains one of the most pressing public health challenges, leaving millions with lasting disabilities each year. When the brain suffers a sudden impact, from a fall, vehicle accident, or sports collision, it triggers inflammation, oxidative stress, and nerve damage that continue long after the initial trauma. Despite decades of research, the traditional diagnosis and treatment strategies often face limitations such as poor detection and inefficient drug delivery. In a ...

Advanced imaging reveals new fungus species in 407-million-year-old plant fossil from Scotland

2025-11-12

Researchers from the Natural History Museum and Sainsbury Laboratory Cambridge University (SLCU) have identified a new species of ancient symbiotic fungus preserved within a 407-million-year-old plant fossil from Scotland. The discovery provides unprecedented three-dimensional insight into one of the earliest known plant–fungus partnerships, known as mycorrhiza. Beyond this discovery, the advanced microscopy techniques used to distinguish the fungus from the surrounding plant cells open a powerful new way to identify fossilised life forms. By analysing their unique ...

Study reveals that flu vaccine performance varies by age

2025-11-12

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age of the patient. Researchers say these findings have the potential to guide vaccine recommendations, especially for older adults. The 2024-2025 flu season was considered highly severe, causing at least 47 million illnesses, 610,000 hospitalizations, and 27,000 deaths. A new study, published in The Journal of Immunology, found that while all four seasonal influenza vaccines produced similar antibody levels, their ability to activate cellular immunity varied greatly depending ...

Narwhals hit moorings—questioning safety assumptions of oceanographic monitoring in the Arctic

2025-11-12

Underwater passive acoustic recording is vital for researchers to monitor and study marine animals in their natural environment with minimal disturbance. “Using passive acoustic monitoring to detect acoustically active animals helps to census biodiversity, understand animal behavior and habitat use, and reduce the negative impacts of human-made noise,” said Associate Professor Evgeny A. Podolskiy of the Arctic Research Center at Hokkaido University in Sapporo, Japan. “For these reasons, scientists increasingly rely on passive acoustic monitoring to answer fundamental ecological questions and manage conservation.” Endemic Arctic whales, ...

The silent threat to our planet that’s easily solved: Light pollution

2025-11-12

New research has revealed for the first time the full extent of how Artificial Light At Night (ALAN) is increasing carbon released by plants and animals across continents – without any increase in the carbon they absorb. The result is reduced carbon storage in ecosystems – which has major implications for climate models and global carbon budgets. Artificial light at night is reshaping carbon balance of whole ecosystems Published in Nature Climate Change, the study from researchers at Cranfield University is the first to demonstrate how ALAN is silently reshaping the carbon balance of ecosystems across ...

Stevens researchers bring hypersonic flight one step closer to take off

2025-11-12

Hoboken, N.J., November 12, 2025 — If it were to become a reality, hypersonic flight, long the realm of science fiction, could revolutionize global travel, transforming day-long international flights into brief commutes no longer than a feature length movie. The duration of a long-haul route, such as Sydney to Los Angeles, might drop from 15 hours to just one. “It really shrinks the planet,” says Professor Nicholaus Parziale, whose research focuses on making such hypersonic flight a reality, and who is a recent recipient of the Presidential Early Career Award for Scientists ...

LAST 30 PRESS RELEASES:

AI can deliver personalized learning at scale, study shows

Study: Plant-based diet can prevent, reverse form of heart disease in animals with hypertension

Lower LRIG1 expression linked to aggressive gliomas

National consortium project led by TU Delft receives huge grant from NWO to build world's largest research digital twins for energy systems

Intranasal oxytocin and physical intimacy for dermatological wound healing and neuroendocrine stress

JMIR Publications partners with Signals to strengthen research integrity across its portfolio

Scientists make dark exciton states shine, unlocking new frontiers for nanotechnology

Glenn Foundation for Medical Research grant programs provide $2.25 million in support for postdoctoral investigators and junior faculty

The mechanisms behind thrombocytopenia in patients with portal hypertension and chronic liver disease

SwRI uses machine learning to calibrate emissions control systems faster, more efficiently

Blood test offers hope for more effective ovarian cancer treatment

Pain during a C-section? New study challenges fears about general anesthesia

New study identifies overlooked tool for menopause symptom relief